The relationship between serum potassium levels and cardiac arrhythmias in left ventricular assist device (LVAD) recipients: a comprehensive analysis and prognostic evaluation

Heart, Artery and Coronary Diseases

Association between pulmonary artery pulsatility and mortality after implantation of left ventricular assist device

ESC Heart Fail

Akamkam A, Galand V, Jungling M, Delmas C, Dambrin C, Pernot M, Kindo M, Gaudard P, Rouviere P, Senage T, Chavanon O, Para M, Gariboldi V, Pozzi M, Litzler PY, Babatasi G, Bouchot O, Radu C, Bourguignon T, D'Ostrevy N, Abi Akar R, Vanhuyse F, Gaillard M, Chatelier G, Fels A, Flecher E, Guihaire J

doi: 10.1002/ehf2.14716

Further Publications

Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy

JACC Heart Fail

Pagani FD, Netuka I, Jorde UP, Katz JN, Gustafsson F, Connors JM, Uriel N, Soltesz EG, Ivak P, Bansal A, Bitar A, Vega JD, Goldstein D, Danter M, Pya Y, Ravichandran A, Conway J, Adler ED, Chung ES, Grinstein J, Dirckx N, Iravani B, Mehra MR

doi: 10.1016/j.jchf.2025.01.017

Therapy and Intervention

Outcomes for Children With Congenital Heart Disease Undergoing Ventricular Assist Device Implantation: An ACTION Registry Analysis

J Am Coll Cardiol

Amdani S, Shezad MF, Kroslowitz B, Townsend M, Joong A, Najm H, Marino BS, Rosenthal DN, Lorts A, O'Connor MJ

doi: 10.1016/j.jacc.2024.10.083

Heart, Artery and Coronary DiseasesTherapy and Intervention

Mortality after cardiac resynchronization therapy or right ventricular pacing in transcatheter aortic valve replacement recipients

Clin Res Cardiol

Kirchner J, Gerçek M, Sciacca V, Reil JC, Guckel D, Potratz M, Omran H, Friedrichs K, Eitz T, Bleiziffer S, Schramm R, Imnadze G, Sohns C, Gummert J, Rudolph V, Rudolph TK, Sommer P, Fink T

doi: 10.1007/s00392-024-02450-1

Heart, Artery and Coronary Diseases

Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

J Am Heart Assoc

Shivakumar N, Friedman DJ, Fudim M, Abraham WT, Cleland JGF, Curtis AB, Gold MR, Kutyifa V, Linde C, Young J, Tang A, Olivas-Martinez A, Inoue LYT, Sanders GD, Al-Khatib SM

doi: 10.1161/JAHA.123.031785

Heart FailureFurther Publications

Vascular function in patients with advanced heart failure and continuous-flow or pulsatile ventricular assist devices

Clin Res Cardiol

Rossi VA, Nebunu D, Nägele MP, Barthelmes J, Haider T, Laptseva N, Bitos K, Kreysing L, Frank M, Enseleit F, Wilhelm MJ, Dzemali O, Ruschitzka F, Sudano I, Flammer AJ

doi: 10.1007/s00392-024-02519-x

Heart, Artery and Coronary Diseases

Decreased Left Ventricular Systolic Function during the Late Phase after Response to Cardiac Resynchronization Therapy

Heart Rhythm

Iwawaki T, Inden Y, Yanagisawa S, Miyamae K, Miyazawa H, Goto T, Kondo S, Tachi M, Shimojo M, Tsuji Y, Murohara T

doi: 10.1016/j.hrthm.2025.02.002

Further Publications

Examining the effectiveness of psychosocial interventions for patients with a cardiac implantable electronic device: A systematic review and meta-analysis

Heart Rhythm

Nicmanis M, Arcangeli O, Chur-Hansen A, Oxlad M

doi: 10.1016/j.hrthm.2025.02.027

Heart, Artery and Coronary DiseasesHeart Failure

Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVER

Eur J Heart Fail

Abdin A, Kondo T, Böhm M, Jhund PS, Claggett BL, Vaduganathan M, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Desai AS, Køber L, Sabatine MS, Petersson M, Bachus E, Solomon SD, McMurray JJV, on behalf of the DAPA‐HF and DELIVER Committees and Investigators

doi: 10.1002/ejhf.3350

Related content

Association between pulmonary artery pulsatility and mortality after implantation of left ventricular assist device

Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy

Outcomes for Children With Congenital Heart Disease Undergoing Ventricular Assist Device Implantation: An ACTION Registry Analysis

Mortality after cardiac resynchronization therapy or right ventricular pacing in transcatheter aortic valve replacement recipients

Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

Vascular function in patients with advanced heart failure and continuous-flow or pulsatile ventricular assist devices

Decreased Left Ventricular Systolic Function during the Late Phase after Response to Cardiac Resynchronization Therapy

Examining the effectiveness of psychosocial interventions for patients with a cardiac implantable electronic device: A systematic review and meta-analysis

Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVER